We are live on ! Find out more
CA

CGN Advisors Portfolio holdings

AUM $1.37B
1-Year Est. Return 15.64%
This Fund
S&P 500
This Quarter Est. Return
+7.14%
1 Year Est. Return
+15.64%
3 Year Est. Return
+44.21%
5 Year Est. Return
+38.41%
10 Year Est. Return
AUM
$1.12B
AUM Growth
+$97.8M
Cap. Flow
+$32M
Cap. Flow %
2.86%
Top 10 Hldgs %
36.81%
Holding
308
New
19
Increased
143
Reduced
113
Closed
12
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBM icon
301
IBM
IBM
$206B
-916
Closed -$228K
IUSV icon
302
iShares Core S&P US Value ETF
IUSV
$27.2B
-2,250
Closed -$208K
KR icon
303
Kroger
KR
$35.9B
-6,263
Closed -$424K
SKX
304
DELISTED
Skechers
SKX
-19,015
Closed -$1.08M
TAXF icon
305
American Century Diversified Municipal Bond ETF
TAXF
$676M
-4,869
Closed -$241K
VPLS
306
Vanguard Core Plus Bond ETF
VPLS
$1.66B
-10,280
Closed -$797K
BSMY
307
Invesco BulletShares 2034 Municipal Bond ETF
BSMY
$139M
-31,215
Closed -$750K
SHYM
308
iShares Short Duration High Yield Muni Active ETF
SHYM
$788M
-9,298
Closed -$211K

Similar funds

CGN Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, CGN Advisors held 308 positions worth $1.12B, up 9.6% from $1.02B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

CGN Advisors's Q2 2025 filing shows 19 new, 143 increased, 113 reduced and 12 closed positions. Its largest new stake was Vanguard Core Tax-Exempt Bond ETF: 93,408 shares worth $6.87M. The largest sale was Vanguard Tax-Exempt Bond Index Fund, an estimated $2.78M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, up from 5.6% a quarter earlier, followed by Financials and Healthcare.

  • CGN Advisors's largest Q2 2025 buy was Vanguard Core Tax-Exempt Bond ETF: 93,408 shares worth $6.87M.
  • CGN Advisors added most to State Street SPDR Portfolio Intermediate Term Corporate Bond ETF in Q2 2025, an estimated $19.9M increase.
  • CGN Advisors's biggest Q2 2025 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $2.78M.
  • CGN Advisors fully exited Charles River Laboratories in Q2 2025, selling an estimated $1.13M.
  • CGN Advisors's ten largest holdings make up 37% of its $1.12B portfolio in Q2 2025.
  • CGN Advisors opened 19 new positions and closed 12 in Q2 2025.
  • CGN Advisors's portfolio value rose 9.6% quarter-over-quarter to $1.12B.

Based on CGN Advisors's 13F filing for Q2 2025, filed 15 Jul 2025.